MedPath

Efficacy of enteral nutrition in adult Ileal Crohn's disease- the RICE study

Conditions
Oral and Gastrointestinal - Crohn's disease
Crohn's disease
Registration Number
ACTRN12616000251426
Lead Sponsor
Concord Hospital, Department of Gastroenterology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Participant must meet all of the inclusion criteria below at time of enrolment to be eligible to participate in phase 1 of the study
1.Crohn’s disease involving the terminal ileum, established diagnosis >6 months
2.Aged 18 – 70 inclusive
3.Ileal complicated Crohn’s disease requiring laparoscopic / open ileal (or small bowel segmental) resection, OR severe ileal Crohn’s disease

Participant must meet all of the inclusion criteria below at time of surgery to be eligible to participate in phase 2 of the study:
1.Crohn’s disease involving the terminal ileum, established diagnosis >6 months
2.Aged 18 – 70 inclusive
3.Ileal complicated Crohn’s disease undergoing laparoscopic / open ileal (or small bowel segmental) resection
4.Terminal ileum can be reached by colonoscopy.

Exclusion Criteria

Participant must not meet any of the exclusion criteria below at time of enrolment to be eligible to participate in either phase 1 or phase 2 of the study
1.Unable to consent, comply or complete the study and associated procedures (such as understanding of questionnaires)
2.Requirement for emergency small bowel resection eg. those with uncontrolled sepsis or peritonitis or complete bowel obstruction
3.Short bowel syndrome or any other significant gastrointestinal disease (eg irritable bowel syndrome, active neoplasm, diverticulitis etc)
4.Colectomy, stoma formation ie. non-primary anastomosis, or strictureplasty without small bowel resection
5.Resection for malignancy or known colorectal dysplasia (apart from polyps that have been completely removed)
6.Pregnancy, lactation or unwillingness to practice an effective method of contraception during the study period
7.Ulcerative colitis or IBD unclassified
8.Comorbidity or psychiatric disorder sufficiently severe to jeopardize participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath